Inventor · disambiguated record
Elaine Chungmin Lee
Also filed as: LEE ELAINE · LEE ELAINE C · LEE ELAINE CHUNGMIN
14 granted patents·15 pending applications·701 citations·filing 1995–2022
95Inventor score
Top patents by PatentIndex Score
29 records- 0198US10081621B2Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamideVERTEX PHARMA·Filed 2015·Granted Sep 25, 2018·29 cites·22 claims
- 0298US9051303B2Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxol-5-YL)-N-(1-(2,3-dihydroxypropyl-6-fluoro-2-(1-hydroxy-2-methylpropan-2-YL)-1H-indol-5-YL)-cyclopropanecarboxamideVERTEX PHARMA·Filed 2014·Granted Jun 9, 2015·59 cites·25 claims
- 0398US8802868B2Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxo1-5-yl)-N-(1-(2,3-dihydroxypropyl-6-fluoro-2-(1-hydroxy-2-methylpropan2-yl)-1H-Indol-5-yl)-CyclopropanecarboxamideVERTEX PHARMA·Filed 2012·Granted Aug 12, 2014·68 cites·40 claims
- 0497US11578062B2Solid forms of (R)-1(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamideVERTEX PHARMA·Filed 2020·Granted Feb 14, 2023·4 cites·19 claims
- 0597US10906891B2Solid forms of (R)-1(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamideVERTEX PHARMA·Filed 2018·Granted Feb 2, 2021·13 cites·14 claims
- 0697US8884018B2Process for preparing modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2014·Granted Nov 11, 2014·62 cites·7 claims
- 0797US8754222B2Process for preparing modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2012·Granted Jun 17, 2014·66 cites·14 claims
- 0897US8344147B2Process for preparing modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2010·Granted Jan 1, 2013·90 cites·24 claims
- 0996US10071979B2Process of producing cycloalkylcarboxamido-indole compoundsVERTEX PHARMA·Filed 2015·Granted Sep 11, 2018·29 cites·28 claims
- 1095US6437106B1Process for preparing 6-o-substituted erythromycin derivativesABBOTT LAB·Filed 2000·Granted Aug 20, 2002·161 cites·30 claims
- 1194US9035072B2Process of producing cycloalkylcarboxamido-indole compoundsBELMONT DANIEL T·Filed 2011·Granted May 19, 2015·62 cites·26 claims
- 1282US2023331712A1Solid forms of (r)-1(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-n-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl)cyclopropanecarboxamideVERTEX PHARMA·Filed 2022·Application pending·0 cites
- 1379US5892008AProcess for the preparation of 6-O-methyl erythromycin a using 9-hydroxy erythromycin derivativesABBOTT LAB·Filed 1997·Granted Apr 6, 1999·46 cites·14 claims
- 1468US2021238158A1Process of producing cycloalkylcarboxamido-indole compoundsVERTEX PHARMA·Filed 2020·Application pending·0 cites
- 1563US6710185B2Process for the preparation of cell proliferation inhibitorsABBOTT LAB·Filed 2001·Granted Mar 23, 2004·2 cites·11 claims
- 1661US2014336393A1Process for preparing modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2014·Application pending·0 cites
- 1760US5760216AUse of synthetic metalloporphyrins for preparation and prediction of drug metabolitesABBOTT LAB·Filed 1995·Granted Jun 2, 1998·10 cites·7 claims
- 1860US2019210991A1Process of producing cycloalkylcarboxamido-indole compoundsVERTEX PHARMA·Filed 2018·Application pending·0 cites
- 1958US2013158071A1Pharmaceutical compositions and administrations thereofVERTEX PHARMA·Filed 2012·Application pending·0 cites
- 2058US2019038615A1Pharmaceutical compositions and administrations thereofVERTEX PHARMA·Filed 2018·Application pending·0 cites
- 2157US2013338188A9Pharmaceutical compositions and administrations thereofVERTEX PHARMA·Filed 2012·Application pending·0 cites
- 2257US2013131107A1Pharmaceutical compositions and administrations thereofVERTEX PHARMA·Filed 2012·Application pending·0 cites
- 2356US2018153874A1Pharmaceutical compositions and administrations thereofVERTEX PHARMA·Filed 2017·Application pending·0 cites
- 2452US2016022665A2Pharmaceutical Compositions and Administrations ThereofVERTEX PHARMA·Filed 2015·Application pending·0 cites
- 2551US2016022664A2Pharmaceutical Compositions and Administrations ThereofVERTEX PHARMA·Filed 2015·Application pending·0 cites
- 2649US2016067239A9Pharmaceutical compositions and administrations thereofVERTEX PHARMA·Filed 2015·Application pending·0 cites
- 2748US2018238808A1Immobilised-Bead Immunomultiplex Cytokine AssayBIMA LTD·Filed 2018·Application pending·0 cites
- 2842US2021009560A1Crystalline forms of modulators of cftrVERTEX PHARMA·Filed 2019·Application pending·0 cites
- 2939US2011251253A1Solid forms of (r)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-n-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl) cyclopropanecarboxamideVERTEX PHARMA·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Elaine Chungmin Lee files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →